Insto investors ‘overreacting’ to ESG scandals



Companies which are the subject of bad environmental, social and governance (ESG) news tend to see greater share price falls as a result, according to a study from Monash University.
The study surveyed 331,000 ESG news events in 23 countries between January 2000 and December 2019, and found institutional investors overestimated the probability of a further shock happening again.
This then led to them having a “stronger tendency to sell” and causing a larger share price fall.
This indicated it was more advantageous for fund managers to wait until the ‘noise’ had passed before making any trade decisions.
“The significant negative abnormal return around ESG controversies – each of these countries had statistically significant negative abnormal returns – indicate that investors shun the company’s stock when it is involved in ESG controversies,” Dr Bei Cui from the Monash Centre for Financial Studies said.
“The research findings show traders have an opportunity to buy these stocks at a discount and then sell at a profit. It also suggests that investors wishing to reduce exposure following bad ESG news can sometimes be better off waiting, in some cases up to 90 days after the announcement – to execute the necessary trades at a better price.”
Cui said there was also evidence news of scandals was being leaked in advance of official announcements as the cumulative abnormal returns tended to occur several days earlier.
Recommended for you
First Sentier Investors chief executive, Mark Steinberg, is set to depart the asset manager after seven years.
Metrics Credit Partners has completed the acquisition of Taurus Finance Group and BC Investment Group as it looks to launch consumer lending arm Navalo.
AMP has announced to the ASX that it is being sued by property fund manager Dexus regarding the sale of its real estate and domestic infrastructure equity business.
Having seen inflows of US$5.6 billion to its fixed income funds in the last quarter, Janus Henderson has closed on a deal with life insurer Guardian to secure funds to boost its product development.